Nutra Pharma Corp (NPHC) Gross Profit (2010 - 2026)

Nutra Pharma has disclosed Gross Profit across 17 years of filings, most recently posting $32625.0 for Q2 2026.

• In Q2 2026, Gross Profit fell 48.56% year-over-year to $32625.0; the TTM figure through Jun 2026 stood at $104269.0 (down 62.74% YoY), while the FY2025 annual figure was $196628.0, down 20.5% from the prior year.
• Gross Profit came in at $32625.0 for Q2 2026 at Nutra Pharma, up from $18975.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $143496.0 in Q4 2022 to a low of -$11907.0 in Q4 2025.
• Average Gross Profit over 5 years is $62201.6, with a median of $64002.0 recorded in 2025.
• Year-over-year, Gross Profit soared 1223.14% in 2023 and sank 113.75% in 2025.
• Over 5 years, Gross Profit stood at $143496.0 in 2022, then tumbled by 34.67% to $93739.0 in 2023, then decreased by 7.63% to $86588.0 in 2024, then slumped by 113.75% to -$11907.0 in 2025, then surged by 374.0% to $32625.0 in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $32625.0 in Q2 2026, $18975.0 in Q1 2026, and -$11907.0 in Q4 2025.